1.
Survival Rate of Gemcitabine Monotherapy after Prior Platinum-based Chemotherapy for Metastatic Bladder Cancer. Cermin Dunia Kedokteran [Internet]. 1 Desember 2022 [dikutip 19 November 2026];49(12):693-701. Tersedia pada: https://cdkjournal.com/index.php/cdk/article/view/329